abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

هذه الصفحة غير متوفرة باللغة العربية وهي معروضة باللغة English

المقال

20 مارس 2015

الكاتب:
Karyn Kaplan, Director, International Hepatitis/HIV Policy & Advocacy, Treatment Action Group

Comment by Karyn Kaplan

إظهار جميع الإشارات

...Gilead is now forcing both doctors and patients in resource-limited settings to jump through unethical hoops before accessing low-cost versions of these drugs. A restrictive anti-diversion clause in their recent license to Indian generic producers forces clinicians to violate basic medical ethics and patient human rights by revealing confidential patient data....

الجدول الزمني